Islam Mohammad Zohurul, Hossain Sheikh I, Deplazes E, Luo Zhen, Saha Suvash C
School of Mechanical and Mechatronic Engineering, University of Technology Sydney 15 Broadway Ultimo 2007 NSW Australia
School of Life Sciences, University of Technology Sydney 15 Broadway Ultimo 2007 NSW Australia
RSC Adv. 2022 Nov 22;12(51):33313-33328. doi: 10.1039/d2ra05268g. eCollection 2022 Nov 15.
Understanding the adsorption mechanism of corticosteroids in the lung surfactant requires the knowledge of corticosteroid molecular interactions with lung surfactant monolayer (LSM). We employed coarse-grained molecular dynamics simulation to explore the action of hydrocortisone on an LSM comprised of a phospholipid, cholesterol and surfactant protein. The structural and dynamical morphology of the lung surfactant monolayer at different surface tensions were investigated to assess the monolayer compressibility. The simulations were also conducted at the two extreme ends of breathing cycles: exhalation (0 mN m surface tension) and inhalation (20 mN m surface tension). The impact of surface tension and hydrocortisone concentration on the monolayer compressibility and stability are significant, resulting the monolayer expansion at higher surface tension. However, at low surface tension, the highly compressed monolayer induces monolayer instability in the presence of the drug due to the accumulation of surfactant protein and drug. The constant area per lipid simulation results demonstrate that the surface pressure-area isotherms show a decrease in area-per-lipid with increased drug concentration. The drug-induced expansion causes considerable instability in the monolayer after a specific drug concentration is attained at inhalation breathing condition, whereas, for exhalation breathing, the monolayer gets more compressed, causing the LSM to collapse. The monolayer collapse occurs for inhalation due to the higher drug concentration, whereas for exhalation due to the accumulation of surfactant proteins and drugs. The findings from this study will aid in enhancing the knowledge of molecular interactions of corticosteroid drugs with lung surfactants to treat respiratory diseases.
了解皮质类固醇在肺表面活性剂中的吸附机制需要掌握皮质类固醇与肺表面活性剂单层(LSM)的分子相互作用。我们采用粗粒度分子动力学模拟来探究氢化可的松对由磷脂、胆固醇和表面活性剂蛋白组成的LSM的作用。研究了不同表面张力下肺表面活性剂单层的结构和动力学形态,以评估单层的压缩性。模拟还在呼吸周期的两个极端点进行:呼气(表面张力为0 mN/m)和吸气(表面张力为20 mN/m)。表面张力和氢化可的松浓度对单层压缩性和稳定性的影响显著,导致在较高表面张力下单层膨胀。然而,在低表面张力下,由于表面活性剂蛋白和药物的积累,高度压缩的单层在药物存在时会导致单层不稳定。每个脂质的恒定面积模拟结果表明,表面压力-面积等温线显示随着药物浓度增加,每个脂质的面积减小。在吸气呼吸条件下达到特定药物浓度后,药物诱导的膨胀会导致单层出现相当大的不稳定性,而对于呼气呼吸,单层会变得更加压缩,导致LSM塌陷。吸气时单层塌陷是由于药物浓度较高,而呼气时是由于表面活性剂蛋白和药物的积累。本研究的结果将有助于增进对皮质类固醇药物与肺表面活性剂分子相互作用的了解,以治疗呼吸系统疾病。